Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • AOP Orphan, Rigi Healthcare AG pharmaceuticals news

    AOP Orphan Pharmaceuticals AG, Vienna, Austria Rigi Healthcare AG, Kuessnacht, Switzerland Business: Pharmaceuticals AOP and Rigi Healthcare created newco Rigi Orphan Inc. USA to in-license, develop and commercialize …

    Published on 5/4/2015
  • Depomed, Actavis neurology news

    Depomed Inc. (NASDAQ:DEPO), Newark, Calif. Actavis plc (NYSE:ACT), Dublin, Ireland Business: Neurology The companies resolved patent litigation related to Depomeds Gralise gabapentin. Under the settlement, Actavis …

    Published on 5/4/2015
  • Medicines Co., Sun Pharmaceutical cardiovascular news

    The Medicines Co. (NASDAQ:MDCO), Parsippany, N.J. Sun Pharmaceutical Industries Ltd. (BSE:524715; NSE:SUNPHARMA), Mumbai, India Business: Cardiovascular The companies resolved patent litigation related to anticoagulant …

    Published on 5/4/2015
  • Pacira neurology news

    Pacira Pharmaceuticals Inc. (NASDAQ:PCRX), Parsippany, N.J. Business: Neurology Pacira said it received a subpoena from the U.S. Department of Justice, U.S. Attorneys Office for the District of New Jersey, requesting …

    Published on 5/4/2015
  • Biogen, Celgene, Pharmacyclics, Hayman Capital Management autoimmune, cancer news

    Biogen Inc. (NASDAQ:BIIB), Cambridge, Mass. Celgene Corp. (NASDAQ:CELG), Summit, N.J. Pharmacyclics Inc. (NASDAQ:PCYC), Sunnyvale, Calif. Hayman Capital Management, Dallas, Texas Business: Autoimmune, Cancer Hedge fund…

    Published on 4/27/2015
  • Amgen, Novartis biosimilars news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Biosimilars The U.S. District Court for the Northern District of California denied a motion from Amgen …

    Published on 4/20/2015
  • Biogen, Forward Pharma autoimmune news

    Biogen Inc. (NASDAQ:BIIB), Cambridge, Mass. Forward Pharma A/S (NASDAQ:FWP), Copenhagen, Denmark Business: Autoimmune Forward said the Patent Trials and Appeals Board of the U.S. Patent and Trademark Office (PTO) …

    Published on 4/20/2015
  • Broad Institute, University of California functional genomics news

    Broad Institute of MIT and Harvard, Cambridge, Mass. University of California, Berkeley, Calif. Business: Functional genomics The University of California Berkeley filed a patent interference request with the U.S. …

    Published on 4/20/2015
  • Eisai cancer, neurology, endocrine/metabolic news

    Eisai Co. Ltd. (Tokyo:4523), Tokyo, Japan Business: Cancer, Neurology, Endocrine/Metabolic Eisais Eisai Inc. U.S. subsidiary plans to cut about 25% of its 1,700-person workforce and will focus on the development of …

    Published on 4/13/2015
  • GeneOne, Inovio, AstraZeneca, Emory University, U.S. Department of Defense, University of Pennsylvania, Vanderbilt University infectious news

    GeneOne Life Science Inc. (KSE:01100), Seoul, South Korea Inovio Pharmaceuticals Inc. (NASDAQ:INO), Blue Bell, Pa. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Emory University, Atlanta, Ga. U.S. Department of …

    Published on 4/13/2015
  • Otsuka Pharmaceutical neurology news

    Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan Business: Neurology Otsuka filed a suit in the U.S. District Court for the District of Maryland alleging that FDA unlawfully broadened the approved indication for Otsukas …

    Published on 4/13/2015
  • Shire, Hayman Capital Management gastrointestinal news

    Shire plc (LSE:SHP; NASDAQ:SHPG), Dublin, Ireland Hayman Capital Management, Dallas, Texas Business: Gastrointestinal A hedge fund filed two inter partes reviews (IPRs) in the Patent Trial and Appeals Board of the U.S. …

    Published on 4/13/2015
  • TransCelerate pharmaceuticals news

    TransCelerate BioPharma Inc., Philadelphia, Pa. Business: Pharmaceuticals Not-for-profit biopharma consortium TransCelerate launched the Placebo/Standard of Care Data Sharing and the e-Labels initiatives. The Placebo/…

    Published on 4/13/2015
  • Veeva Systems, Zephyr Health bioinformatics news

    Veeva Systems, Pleasanton, Calif. Zephyr Health Inc., San Francisco, Calif. Business: Bioinformatics Zephyr joined Veevas OpenKey partner program under a data access agreement to provide life sciences companies with …

    Published on 4/13/2015
  • Amgen, Novartis biosimilars news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Biosimilars Novartis Sandoz Inc. generics unit filed an opposition brief to Amgens motion seeking a …

    Published on 4/6/2015
  • BioCryst, U.S. Department of Health and Human Services infectious news

    BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX), Durham, N.C. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious HHSs Biomedical Advanced Research and Development Authority (BARDA) awarded …

    Published on 4/6/2015
  • Catamaran, UnitedHealth Group other news

    Catamaran Corp. (NASDAQ:CTRX; TSX:CCT), Schaumburg, Ill. UnitedHealth Group Inc. (NYSE:UNH), Minneapolis, Minn. Business: Other The OptumRx Inc. pharmacy benefit manager unit of UnitedHealth will acquire fellow PBM …

    Published on 4/6/2015
  • Vivus endocrine/metabolic news

    Vivus Inc. (NASDAQ:VVUS), Mountain View, Calif. Business: Endocrine/Metabolic Vivus plans to reduce contractual sales representatives for obesity drug Qsymia phentermine/topiramate to about 100 from about 150. The …

    Published on 4/6/2015
  • AcelRx Pharmaceuticals Inc neurology news

    AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX), Redwood City, Calif. Business: Neurology AcelRx will reduce headcount by 19 (36%) to focus resources on seeking FDA approval of Zalviso sufentanil sublingual tablet system and …

    Published on 3/30/2015
  • Amgen Inc, Novartis biosimilars news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Biosimilars Amgen filed an appeal in the U.S. Court of Appeals for the Federal Circuit (CAFC) of a …

    Published on 3/30/2015
  • Emergent BioSolutions Inc, U.S. Department of Health and Human Services infectious news

    Emergent BioSolutions Inc. (NYSE:EBS), Rockville, Md. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious HHSs Biomedical Advanced Research and Development Authority (BARDA) awarded …

    Published on 3/30/2015
  • Forma Therapeutics, Cancer Research UK cancer news

    Forma Therapeutics Inc., Watertown, Mass. Cancer Research UK, London, U.K. Business: Cancer Forma and the not-for-profits commercial arm, Cancer Research Technology Ltd., launched two virtual companies to develop …

    Published on 3/30/2015
  • Amgen, Novartis biosimilars news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Biosimilars The U.S. District Court for the Northern District of California denied Amgens motions seeking …

    Published on 3/23/2015
  • Biogen Idec, Eli Lilly, GlaxoSmithKline, J&J, Pfizer, Alzheimers Research UK, U.K. Department of Health neurology news

    Biogen Idec Inc.(NASDAQ:BIIB), Cambridge, Mass. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Pfizer Inc. (NYSE:…

    Published on 3/23/2015
  • Discovery Laboratories pulmonary news

    Discovery Laboratories Inc. (NASDAQ:DSCO), Warrington, Pa. Business: Pulmonary Discovery Laboratories disclosed in its 2014 financial results that it will restructure to focus on development of Aerosurf aerosolized KL4…

    Published on 3/23/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993